Profiel
Oliver Buck is the founder of OncoBeta GmbH.
He is currently a Trustee at the International Centers for Precision Oncology Foundation and a Member-Supervisory Board at ITM Isotope Technologies Munich SE.
Previously, he served as a Non-Independent Non-Executive Director at Telix Pharmaceuticals Ltd. from 2017 to 2022.
Mr. Buck graduated from Technische Universität München.
Actieve functies van Oliver Buck
| Bedrijven | Functie | Begin |
|---|---|---|
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Directeur/Bestuurslid | 01-01-2012 |
International Centers for Precision Oncology Foundation | Directeur/Bestuurslid | - |
Eerdere bekende functies van Oliver Buck
| Bedrijven | Functie | Einde |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Directeur/Bestuurslid | 18-05-2022 |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Oprichter | - |
Opleiding van Oliver Buck
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Technische Universität München
Technische Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
OncoBeta GmbH
OncoBeta GmbH Medical SpecialtiesHealth Technology Operates as a medical device and radiochemical company | Health Technology |
International Centers for Precision Oncology Foundation | |
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Pharmaceuticals: MajorHealth Technology Manufactures and supplies medical radioisotopes for diagnosis and targeted treatment of various cancer indications | Health Technology |
















